Validation analyses for ANGPTL4 as independent predictor of left ventricular mass in chronic obstructive pulmonary disease
| LV mass | ||||
|---|---|---|---|---|
| Coefficient B (95% CI) | Standardized β | p Value | Total R2 | |
| Unadjusted models | ||||
| log-ANGPTL4, ng/mL | 17.8 (8.2 to 27.4) | 0.30 | <0.001 | 0.089 |
| Adjusted models* | ||||
| log-ANGPTL4, ng/mL | 16.1 (6.8 to 25.4) | 0.27 | <0.001 | 0.345 |
Two separate linear regression analyses are shown for the validation cohort of patients with COPD. ANGPTL4 was log-transformed to obtain a normal distribution.
*The adjusted regression models included the same adjustments like in the model for NT-proBNP (see tables 2 and 3), that is, age, sex, body mass index, smoking status, the metabolic syndrome, LDL cholesterol, FEV1, hs-CRP and history of CAD.